2-(norbornan-2-yl)ethyl bromide | 131665-74-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 2-(norbornan-2-yl)ethyl bromide
• 英文别名: 1-bromo-2-(2-norbornyl)ethane；2-(2-norbornyl)ethylbromide；2-(2-bromo-ethyl)-bicyclo[2.2.1]heptane；2-(2-bromoethyl)bicyclo[2.2.1]heptane
• CAS: 131665-74-2
• 化学式: C₉H₁₅Br
• 分子量: 203.122
• InChiKey: ULEUMUYIYXETME-UHFFFAOYSA-N

物化性质

• 沸点：
  208.0±8.0 °C(Predicted)
• 密度：
  1.302±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  2-(norbornan-2-yl)ethyl bromide 在 正丁基锂 作用下， 生成 2-(2-norbornyl)ethyl-2-ethoxycarbonyl-1,3-dithiane
  参考文献：
  名称：

  A Novel Method for the Preparation of α,α‘-Difluoroesters and Acids Using BrF₃

  摘要：

  Alkyl-, haloalkyl-, and ketoalkyl-2-ethoxycarbonyl-1,3-dithianes were easily made from the appropriate primary or secondary alkyl bromides, 1,3-dithiane, and ethyl chloroformate. They were reacted with BrF3 to form the corresponding alpha,alpha-difluoro esters in 65-75% yield. Reaction conditions are very mild (1-2 min, 0 degreesC). The two sulfur atoms of the dithiane are essential for the reaction.

  DOI：

  10.1021/jo034829i
• 作为产物：
  描述：

  2-降莰烷乙酸 在 N-溴代丁二酰亚胺(NBS) 、 lithium aluminium tetrahydride 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 14.0h， 生成 2-(norbornan-2-yl)ethyl bromide
  参考文献：
  名称：

  WO2008/114971

  摘要：

  公开号：

文献信息

• NOVEL BENZAMIDE DERIVATIVES AND PROCESS FOR THE PREPARTION THEREOF
  申请人：Yoo Moo-Hi

  公开号：US20100105727A1

  公开（公告）日：2010-04-29

  The present invention provides a novel benzamide derivative represented by formula 1 and an isomer, a pharmaceutically acceptable salt or hydrate thereof, and a composition for activating a 5-HT4 receptor comprising the same, as an active ingredient. Benzamide derivatives of the present invention has superior affinity for 5-HT4 receptors, capability to reduce the gastric evacuation time, capability to alleviate ventricular tachycardia, ventricular fibrillation, torsades de pointes and QT prolongation, and low toxicity. Therefore, benzamide derivatives of the present invention are therapeutically effective for digestive system diseases.

  本发明提供了一种新颖的苯甲酰胺衍生物，其由式1表示，以及一个异构体，其药学上可接受的盐或水合物，以及包含相同物质的用于激活5-HT4受体的组合物，作为活性成分。本发明的苯甲酰胺衍生物具有优越的亲和力，能够减少胃排空时间，能够缓解室性心动过速、室颤、扭转型室性心动过速和QT间期延长，并且毒性低。因此，本发明的苯甲酰胺衍生物在治疗消化系统疾病方面具有治疗效果。
• Novel Method for Incorporating the CHF₂ Group into Organic Molecules Using BrF₃
  作者：Revital Sasson、Aviv Hagooly、Shlomo Rozen

  DOI：10.1021/ol034051n

  日期：2003.3.1

  3-dithiane derivatives, easily made from alkyl bromides and the parent 1,3-dithiane, were reacted with BrF(3) to form the corresponding 1,1-difluoromethyl alkanes (RCHF(2)) in 60-75% yield. The reaction proceeds well with primary alkyl halides. The limiting step for secondary alkyl halides is the relatively low yield of the dithiane preparation. The two sulfur atoms of the dithiane are essential for

  由烷基溴和母体1,3-二噻吩容易制得的2-烷基-1,3-二噻烷衍生物与BrF（3）反应形成60中的相应1,1-二氟甲基烷烃（RCHF（2）） -75％的产率。该反应与伯烷基卤化物进行得很好。仲烷基卤化物的限制步骤是二噻烷制剂的相对较低的收率。二噻吩的两个硫原子对于反应是必不可少的。
• From Alkyl Halides to Alkyltrifluoromethyls Using Bromine Trifluoride
  作者：Aviv Hagooly、Iris Ben-David、Shlomo Rozen

  DOI：10.1021/jo026128b

  日期：2002.11.1

  right conditions, bromine trifluoride can be a useful tool for generating new types of reactions and compounds. Thus, tris(methylthio)alkyl derivatives, easily prepared from the corresponding alkyl bromides, were converted to the corresponding RCHBrCF2SMe or RCHBrCF3 compounds. The bromine atom, however, could be easily reduced forming eventually R'CF2SMe or R'CF3. If desired, the bromine atom can serve

  在适当的条件下，三氟化溴可能是产生新型反应和化合物的有用工具。因此，容易从相应的烷基溴制备的三（甲硫基）烷基衍生物被转化为相应的RCHBrCF2SMe或RCHBrCF3化合物。但是，溴原子很容易还原，最终形成R'CF2SMe或R'CF3。如果需要，溴原子可以用作构建末端二氟烯烃的入口。
• Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
  申请人：——

  公开号：US20040072843A1

  公开（公告）日：2004-04-15

  This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.

  这项发明涉及一种新型磺酰胺取代的色苷衍生物，其在治疗β-3受体介导的疾病中有用。
• Compounds useful for preparation of Beta-3 adrenoreceptor agonist
  申请人：——

  公开号：US20030073839A1

  公开（公告）日：2003-04-17

  This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.

  本发明涉及新型磺酰胺取代的色甘醇衍生物，其在治疗β-3受体介导的疾病方面有用。